Risking 1.5% in Dr LAL PATH LABS for the reward of 7.5%
Dr Lal PathLabs net profit zooms 54% to Rs 81.3 crore in Q3. Yet the stock is consolidating in the same place for a week, even 
CNXPHARMA is trading at the ATH. This might be a very good chance to enter at below price of 2400 (2394) with 1.5% stoploss.
CNXPHARMA is trading at the ATH. This might be a very good chance to enter at below price of 2400 (2394) with 1.5% stoploss.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.